Drug Trial Radar · NCT07172893
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Dec 10, 2025
Primary completion
Oct 1, 2026
Study completion Oct 15, 2026
Sponsor
- Lead sponsor
- HealthTech Wound CareIndustry
- Sponsor type
- Industry
- First posted
- Sep 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Conditions
- Diabetic Foot Ulcer (DFU)
- Venous Leg Ulcer (VLU)
Interventions
DermaBind TLBiological
Full-Thickness Dehydrated Placental Allograft
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measure the protective effect of the wound covering on the wound over the 13-week treatment periodTime frame: 13 weeks
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Midland Florida Clinical Research Center
DeLand, Florida
Pharmakon Medical Research
Palm Beach Gardens, Florida
Vital Medical Research
Sweetwater, Florida
EMbassy Research Network
Bloomfield Township, Michigan
US Foot and Ankle Specialists-Cary Satellite Site
Cary, North Carolina
US Foot and Ankle Specialists
Raleigh, North Carolina
US Foot and Ankle Specialists
Blue Ash, Ohio
Lower Extremity Institute for Research and Therapy
Boardman, Ohio
Perfizien Clinical Research, LLC.
Houston, Texas
Foot and Ankle Specialists of the Mid-Atlantic
Salem, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.